Natural preservatives
Search documents
Is International Flavors & Fragrances Stock Underperforming the S&P 500?
Yahoo Finance· 2026-03-13 11:53
Company Overview - International Flavors & Fragrances Inc. (IFF) has a market capitalization of $17.9 billion and operates in the food, beverage, health, biosciences, and fragrance industries through four main segments: Taste, Food Ingredients, Health & Biosciences, and Scent [1] - The company develops flavor solutions for various products, including beverages, dairy, snacks, bakery items, and savory foods, as well as specialty ingredients and natural preservatives [2] Stock Performance - IFF shares have decreased by 17.1% from their 52-week high of $84.45, but have increased by 10.7% over the past three months, outperforming the S&P 500 Index, which declined by 2.3% during the same period [3] - Year-to-date, IFF stock is up 3.9%, while the S&P 500 Index has dropped by 2.5%. However, over the past 52 weeks, IFF shares have declined nearly 12%, lagging behind the S&P 500 Index's return of 19.2% [4] Financial Performance - Following the Q4 2025 results released on February 11, IFF shares rose by 5.9%. In this quarter, adjusted operating EBITDA increased by 7% to $437 million, and adjusted EPS reached $0.80, reflecting productivity gains and cost discipline [5] - The company provided guidance for 2026, projecting sales between $10.5 billion and $10.8 billion, and adjusted operating EBITDA between $2.05 billion and $2.15 billion, alongside strategic actions such as initiating a sale process for the Food Ingredients segment to enhance portfolio focus and financial flexibility [5] Competitive Position - IFF's stock performance has been weaker compared to its rival, Linde plc (LIN), which has returned 15% year-to-date and 8.7% over the past 52 weeks [6]
Corbion (OTCPK:CSNV.Y) 2025 Capital Markets Day Transcript
2025-11-20 10:02
Corbion Capital Markets Day Summary Company Overview - **Company**: Corbion (OTCPK:CSNV.Y) - **Event**: 2025 Capital Markets Day - **Date**: November 20, 2025 - **Key Focus**: Transition from Advance 2025 to Bright 2030 strategic plan Key Achievements and Financial Performance - **Advance 2025 Achievements**: - Margin expansion from 13% to 16% [1] - 10 consecutive quarters of positive free cash flow [1] - Top-line CAGR of 9% and EBITDA growth of 8% [2] - Specialty food and green business volume mix grew by 4% [1] - **Bright 2030 Goals**: - Targeting 3%-6% annual top-line sales growth for 2026-2028 [2] - Adjusted EBITDA margin goal of 18% [2] - Cumulative free cash flow target of EUR 270 million [2] Strategic Focus Areas - **Natural Preservation and Nutrition**: - Emphasis on clean label and natural ingredients due to consumer demand [3][4] - Regulatory pressures favoring sustainable food solutions [4] - Focus on functional foods due to aging population and health awareness [4] - **Market Dynamics**: - Addressable market for food preservation is nearly $3.5 billion, with a combined opportunity of $7 billion when including shelf life extension [6] - Nutrition market, including omega-3s, is also valued at nearly $7 billion, growing at 2%-6% per annum [7] Innovation and Technology - **Fermentation Technology**: - Unique ability to scale from lab to industrial production [9] - New lactic acid plant in Thailand enhances sustainability and cost efficiency [10][16] - Circular manufacturing process reduces carbon footprint [13] - **Product Portfolio**: - Focus on natural antimicrobials, antioxidants, and acidification solutions [27][28] - Successful replacement of synthetic ingredients with natural alternatives [30] Sustainability Commitment - **Climate Goals**: - Aim for net-zero emissions across the value chain by 2050 [21] - 99% of raw materials are verified deforestation-free [21] - Natural preservation solutions help prevent over 10 million tons of food waste annually [19] Financial Outlook - **Medium-Term Financial Targets**: - Organic sales growth of 3%-6% per annum [51] - Adjusted EBITDA margin improvement to around 18% by 2028 [51] - Cumulative free cash flow of around EUR 270 million over the next three years [51] - **Capital Allocation**: - Balanced approach focusing on organic growth and shareholder returns [58] - Anticipated CapEx around 6% of sales [62] Conclusion - Corbion is well-positioned to capitalize on market trends towards natural ingredients and sustainability, with a strong focus on innovation and operational efficiency. The Bright 2030 strategy aims to enhance growth and profitability while maintaining a commitment to environmental responsibility and consumer health.